<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100968638</journal-id>
<journal-id journal-id-type="pubmed-jr-id">29770</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Transplant</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Transplant.</journal-id>
<journal-title-group>
<journal-title>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</journal-title>
</journal-title-group>
<issn pub-type="ppub">1600-6135</issn>
<issn pub-type="epub">1600-6143</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26601915</article-id>
<article-id pub-id-type="pmc">5672809</article-id>
<article-id pub-id-type="doi">10.1111/ajt.13623</article-id>
<article-id pub-id-type="manuscript">NIHMS916334</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glutamate receptor interacting protein 1 regulates CD4<sup>+</sup> CTLA-4 expression and transplant rejection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Modjeski</surname>
<given-names>K.L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Levy</surname>
<given-names>S.C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ture</surname>
<given-names>S.K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Field</surname>
<given-names>D.J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ko</surname>
<given-names>K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Q.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morrell</surname>
<given-names>C.N.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA</aff>
<aff id="A2">
<label>2</label>Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA</aff>
<author-notes>
<corresp id="FN1"><bold>Correspondence:</bold> Craig N. Morrell DVM, PhD; <email>craig_morrell@urmc.rochester.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>Disclosures: The authors of this manuscript have no conflicts of interest to disclose as described by the <italic>American Journal of Transplantation</italic>.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>06</day>
<month>11</month>
<year>2017</year>
</pub-date>
<volume>16</volume>
<issue>5</issue>
<fpage>1383</fpage>
<lpage>1393</lpage>
<!--elocation-id from pubmed: 10.1111/ajt.13623-->
<abstract>
<p id="P1">PDZ domains are common 80–90 amino acid regions named after the first three proteins discovered to share these domains: post-synaptic density 95, disc large, and zonula occludens. PDZ domain-containing proteins typically interact with the C-terminus of membrane receptors. Glutamate receptor interacting protein 1 (GRIP1), a 7 PDZ domain protein scaffold regulates glutamate receptor surface expression and trafficking in neurons. We have found that human and mouse T cells also express GRIP1. T cell-specific GRIP1<sup>−/−</sup> mice greater than 11 weeks of age had prolonged cardiac allograft survival. Compared to WT T cells, in vitro stimulated GRIP1<sup>−/−</sup> T cells had decreased expression of activation markers, and increased apoptotic surface marker expression. Surface expression of the strong T cell inhibitory molecule CTLA-4 was increased on GRIP1<sup>−/−</sup> T cells from mice greater than 11 weeks of age. CTLA-4 increases with T cell stimulation and its surface expression on GRIP1<sup>−/−</sup> T cells remained high after stimulation was removed indicating a possible internalization defect in GRIP1 deficient T cells. CTLA-4 blocking antibody treatment following heart transplantation led to complete rejection in T cell GRIP1<sup>−/−</sup> mice indicating that increased CTLA-4 surface expression contributed to the extended graft survival. Our data indicates that GRIP1 regulates T cell activation by regulating CTLA-4 surface expression.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>